✦ LIBER ✦

Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis: A Randomized, Double-Blind, Multicenter Study

✍ Scribed by Lindberg, J. S.

Book ID: 120457733
Publisher: Lippincott Williams and Wilkins
Year: 2005
Tongue: English
Weight: 175 KB
Volume: 16
Category: Article
ISSN: 1046-6673
DOI: 10.1681/ASN.2004060512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical assessment of ramosetron HCl or

Clinical assessment of ramosetron HCl oral preparation in the treatment of nausea and vomiting induced by cisplatin: A multicenter, randomized, parallel-design, double-blind comparative study with ondansetron HCl

✍ Kiichiro Noda; Masanori Ikeda; Tetsuo Taguchi; Ryunosuke Kanamaru; Motohiko Ichi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 824 KB

Randomized, Double-Blind, Multicenter Ph

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

✍ Oldach, D.; Clark, K.; Schranz, J.; Das, A.; Craft, J. C.; Scott, D.; Jamieson, 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 253 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi